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7RESEARCH Open AccessMycoplasma bovis infections in Swiss dairy cattle:
a clinical investigation
Marlis Aebi1, Bart HP van den Borne2, Andreas Raemy1, Adrian Steiner1, Paola Pilo3 and Michèle Bodmer1*Abstract
Mycoplasma bovis causes mastitis in dairy cows and is associated with pneumonia and polyarthritis in cattle. The
present investigation included a retrospective case–control study to identify potential herd-level risk factors for M. bovis
associated disease, and a prospective cohort study to evaluate the course of clinical disease in M. bovis infected dairy
cattle herds in Switzerland. Eighteen herds with confirmed M. bovis cases were visited twice within an average interval
of 75 d. One control herd with no history of clinical mycoplasmosis, matched for herd size, was randomly selected
within a 10 km range for each case herd. Animal health data, production data, information on milking and feeding-
management, housing and presence of potential stress- factors were collected. Composite quarter milk samples were
aseptically collected from all lactating cows and 5% of all animals within each herd were sampled by nasal swabs.
Organ samples of culled diseased cows were collected when logistically possible. All samples were analyzed by
real-time polymerase chain reaction (PCR). In case herds, incidence risk of pneumonia, arthritis and clinical mastitis
prior to the first visit and incidence rates of clinical mastitis and clinical pneumonia between the two visits was
estimated. Logistic regression was used to identify potential herd-level risk factors for M. bovis infection. In case
herds, incidence risk of M. bovis mastitis prior to the first visit ranged from 2 to 15%, whereas 2 to 35% of the
cows suffered from clinical pneumonia within the 12 months prior to the first herd visit. The incidence rates of
mycoplasmal mastitis and clinical pneumonia between the two herd visits were low in case herds (0–0.1 per
animal year at risk and 0.1-0.6 per animal year at risk, respectively). In the retrospective-case-control study high
mean milk production, appropriate stimulation until milk-let-down, fore-stripping, animal movements (cattle
shows and trade), presence of stress-factors, and use of a specific brand of milking equipment, were identified as
potential herd-level risk factors. The prospective cohort study revealed a decreased incidence of clinical disease
within three months and prolonged colonization of the nasal cavity by M. bovis in young stock.
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Bovine mycoplasmosis due to Mycoplasma bovis has
caused major economic losses in the USA and Canada
for several years, inducing mastitis [1,2], respiratory dis-
ease [3], and polyarthritis [4]. Both dairy and beef cattle
have been affected [5]. Mycoplasma species most fre-
quently associated with outbreaks of mycoplasmal mas-
titis in North America have been identified as M. bovis,
followed by M. alkalescens, M. bovigenitalium, M. cali-
fornicum and M. canadense [2]. To date, no effective
therapy of mastitis and only limited success in treatment* Correspondence: michele.bodmer@vetsuisse.unibe.ch
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unless otherwise stated.of respiratory and joint diseases [6,7] caused by M. bovis
have been reported. Moreover, vaccines have not proved
to be protective [3,8]. In Europe, reports have also docu-
mented the association between M. bovis and mastitis,
pneumonia and polyarthritis [9-11]. Tschopp et al. [12]
investigated respiratory infections in veal calves and re-
ported that 50.3% of clinical respiratory episodes were
attributable to M. bovis. In Switzerland, a seroprevalence
study was performed by Burnens et al. [13] following an
outbreak of M. bovis-associated pneumonia. That study
showed a between-herd sero-prevalence of 47% and a
cow level sero-prevalence of 6.1% in M. bovis antibody
positive herds, implying that a large percentage of herds
had been in contact with M. bovis, but only very few ani-
mals within the herds seroconverted. This pattern isis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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such as feedlots where an overall M. bovis seropreva-
lence of 33.3% in one feedlot was observed [14]. In feed-
lots investigated in France, one M. bovis strain became
predominant during the fattening period and was re-
sponsible for severe outbreaks of bovine respiratory dis-
ease (BRD) with high within-group prevalences [15].
Several authors [16,17] have suggested that mycoplasmas
are frequently present in the cattle population, causing
disease only if specific conditions are met. Such circum-
stances can occur if animals’ immune response is impaired
due to stress such as inadequate feeding, transportation or
low environmental temperatures [17,18]. Punyaporn-
withaya et al. [19] found that the colonization of different
body sites with one specific M. bovis strain was re-
sponsible for a mastitis epidemic within a herd. Add-
itionally, hematogenous spread of specific strains may
occur after infection of one organ system [20]. Most
recently, Spergser et al. [21] described an outbreak of M.
bovis on a communal Alpine farm caused by one specific
strain. During the last 2 to 3 years, incidental field reports
have indicated an increase in number of outbreaks due to
M. bovis in Swiss dairy cattle herds, mainly associated with
the development of mastitis and pneumonia.
The aim of this study was to collect clinical and epi-
demiological data on mycoplasmal outbreaks in Swiss
dairy cattle herds and to identify potential herd-level risk
factors associated with clinical M. bovis-related disease
using a retrospective case–control study. Additionally,
the course of mycoplasmal disease in M. bovis infected
herds that received recommendations for improvement
was assessed using a prospective cohort study design.
Methods
Herd selection
In order to recruit herds with mycoplasmosis, the pro-
ject had been announced to routine diagnostic laborator-
ies by letter and practicing veterinarians in Switzerland
by e-mail and announcements at seminars for continu-
ous education. From April 2010 till October 2011, af-
fected herds were reported. These herds, which had at
least one animal with clinical signs of mastitis, pneumo-
nia or arthritis and at least one M. bovis polymerase
chain reaction (PCR) or culture positive sample in mate-
rials such as milk, broncho-alveolar lavage fluids, nasal
swabs, lung or mammary gland-tissue during the last
3 months before study enrollment were included in the
study and were defined as case herds.
To have balanced study groups, one control herd was
selected for each case herd taking into account the herd
size and geographical distance to the case herd. The
Swiss Animal Movement Database was consulted to
identify five neighboring herds located within a 5 km
range from the case herd and with a similar herd size(+/−10 cows). If no herds were located within 5 km of
the case herd, the radius was increased to 10 km. From
this list, one herd was randomly selected and contacted
with a request to participate. These herds were defined
as control herds, given the additional requirement that
they did not have a history of clinical disease caused by
M. bovis within the past 12 months, which was reported
by the farmer and confirmed by the attending veterinar-
ian, respectively.
Definition of clinical cases
Clinical pneumonia in cows and calves was defined as a
condition with elevated body temperature, elevated re-
spiratory rate, pathological lung sounds and coughing. A
case of clinical mastitis was defined by abnormal
changes in milk secretion and/or swelling of affected
quarters with or without systemic symptoms such as ele-
vated body temperature. Subclinical mastitis was defined
as a somatic cell count >150,000 cells/ml without
changes in secretion or swelling of affected quarters.
Arthritis was defined as distinct swelling of one or more
joints with or without lameness.
Collection of herd data and clinical samples
During the first and second visits to case and control
herds, the same structured questionnaire was used to as-
sess farm data. At each herd visit, housing, milking sys-
tem, milking routine and calf management were
evaluated. The questions concerned general farm infor-
mation covering the topics housing system, animal
movements (trade, cattle shows) and milking system.
The age-specific number of cases with a clinical diagno-
sis of pneumonia or arthritis within the last 12 months
was recorded with the aid of treatment records for
young stock or adults separately. Mastitis cases caused
by M. bovis, as confirmed by either PCR or bacterio-
logical culture within the 3-months-period prior to the
first visit, were also recorded. Milking hygiene and milk-
ing routine were observed during milking and included
sequence of work steps during udder preparation, pres-
ence of a milking order according to udder health status
of the individual cows, and post milking teat disinfec-
tion. Intensive animal movements (animal traders and
herds with >5 transportations per year) and presence of
concomitant disease within the previous 12 months such
as puerperal metritis, displacement of abomasum, post-
partum hypocalcaemia (“milk fever”) and clinical ketosis
were assessed by consulting farm records. Overcrowd-
ing, high in-barn temperature (>24°C) and impaired feed
quality were listed as stress-factors. Overcrowding was
regarded as present if not all animals of one housing-
unit (i.e. one row of cows in a tie stall, one deep straw
box for group housing of calves) were able to lie down
at the same time including a cubicle-to-cow ratio <1 for
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assessed by visual and olfactory inspection for presence
of molds and for secondary fermentation of silages, re-
spectively. An overview of the data collected on farms
and management is given in Table 1.
At the first and second herd visit, composite foremilk
samples were aseptically collected from all lactating
cows of case and control herds during milking time. Dry
nasal swabs (Transwab Amies, Medical Wire & Equip-
ment, Wiltshire, UK), were collected from all age groups
in both case and control herds as a convenience sample
from at least 5% of cows present at the visit, including
healthy animals, in order to detect subclinical carriers of
M. bovis. The nasal swabs were transported to the la-
boratory without any transport medium. Additionally,
lung and mammary gland tissues of clinically diseased
cows that were culled were collected from the abattoir if
logistically possible. All samples were transported at 5°C
to the Institute of Veterinary Bacteriology, Vetsuisse Fac-
ulty Berne for M. bovis analysis.Table 1 On-farm questionnaire: overview on the data collecte
Topic Descript
Cow husbandry Housing
(rubber m
chopped
flooring
Calf husbandry Group h
(deep str
from lac
Heifer rearing Own rep
farm (ye
Communal alpine pasturing Heifers o
Feeding management, ration
of lactating cows
Changes
changes
Quality of feed fed to cows Smell (ar
visual ins
within th
Feeding management of calves Bucket fe
automat
to calves
Milking system Type of
brand of
3 month
Milking routine Grouping
impleme
disinfect
disinfect
(yes vs. n
Animal movement Number
(<5 trans
Overcrowding All anim
cubicle t
Environmental factors Tempera
Concomitant disease in
animals suffering from
confirmed mycoplasmosis
Retained
of abomFor the prospective cohort study, farmers from case herds
were given general advice on how to proceed with M. bovis
suspected and positive animals and how to optimize their
management concerning mastitis and pneumonia to avoid
new infections of M. bovis susceptible animals, based on lit-
erature [2,21-23]. The recommendations included isolating
and culling all positive animals with clinical mastitis. Also,
isolating and treating animals with symptoms of severe
pneumonia and positive nasal swabs with oxytetracyclin
(Oxysentin, Novartis, Basle, Switzerland, 10 mg/kg per day,
intravenously) for at least 7 days was advised, in addition to
applying non-steroidal anti-inflammatory drugs (NSAID).
The advice to improve milking hygiene and milking routine
included the implementation of a strict milking order: 1.
low somatic cell count cows, with no clinical signs of pneu-
monia or arthritis, 2. suspect cows either with unclear M.
bovis status or signs of pneumonia and polyarthritis, and 3.
M. bovis positive cows (milk). Udder preparation should in-
clude the following steps in the given order: 1. fore strip-
ping; 2. cleaning of teats (1 towel/cow); 3. attachment ofd on the farms
ion
system (free-stall vs. tie-stall), lying area
ats with saw dust, rubber mats with
straw, straw bedding, chalk-straw bedding, other),
(rubber mats, concrete, slatted floor, other),
ousing vs. individual igloos, bedding type
aw bedding vs, other bedding), separate
tating cows (yes vs. no)
lacements (yes vs. no), rearing on another
s vs. no)
nly (yes vs. no), cows and heifers (yes vs. no)
in the ration within the last 3 months (yes vs. no),
in feeding management (yes vs. no)
omatic vs. moldy, alcoholic), heating of silage (by hand),
pection (presence of molds), changes in feed quality
e last 3 months (yes vs. no)
eding (individual bucket vs. one bucket for several calves),
ic feeding system (yes vs. no), feeding mastitis milk
(yes vs. no)
milking system (parlor vs. bucket milk unit vs. pipeline system),
milking system, changes in the milking system within the last
s (yes vs. no)
of mastitic and susceptible cows, milking routine (order and
ntation of individual steps), teat cleaning material (no cleaning,
ant towel, dry paper towel, wood wool, other), post milking teat
ion, (yes vs no), changes in milking routine within the last 3 months
o)
of purchased animals within the last 12 months, sporadic transportations
portations per year), expositions (>5 movements per year), animal trade
als in one housing unit can lie down at the same time (yes vs. no),
o cow ratio 1:1 or higher in loose housing systems (yes vs. no)
ture > 24°C (yes vs. no), building work in progress (yes vs. no)
fetal membranes, hypocalcaemia, puerperal metritis, displacement
asum, primary ketosis, lameness caused by claw disorders
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of clusters with interruption of vacuum, and 5. post-
milking teat disinfection with a disinfecting solution,
preferably containing iodophores, immediately after
cluster removal. To prevent new M. bovis infections in
young animals, the owners were advised to house all
young stock separately from the cows, to isolate calves
with pneumonia, to avoid feeding calves with milk
from cows with mastitis and to use individual feeding
buckets. On-farm pasteurization of raw milk as de-
scribed by Butler et al. [24] to feed dairy calves is not
routinely practiced in Switzerland and was therefore
not considered as a potential control measure in this
study.
Eighteen case herds were visited a second time within
a mean interval of 75 d (SD 20 d) from the first visit in
order to retest all lactating cows for the presence of M.
bovis, to assess ongoing transmission within the herd
and to test first calving heifers and cows that had been
dried off at the first visit. One case herd was not visited
a second time since it was owned by an animal trader
and most of the cows were sold or moved to other farms
belonging to the same owner at the time of the second
visit.
The cohort study focused on the course of clinical M.
bovis-associated disease in case herds. Nevertheless, 9
control herds were visited a second time and investi-
gated using the same structured questionnaire in order
to confirm freedom from M. bovis. Sampling in case and
control herds was performed according to the same
protocol used at the first visit, except for nasal swabs
where a different convenience sample of animals was
used. Farmers were encouraged to send in milk samples
for PCR analysis of cows suspected of mycoplasmal mas-
titis between the two herd visits and to take the rectal
temperature and call their veterinarians for cows sus-
pected of clinical pneumonia. No further investigations
on pathogens were recommended.
Laboratory testing
In order to identify M. bovis positive animals, milk, nasal
swabs and organs were tested for M. bovis by a direct
real-time PCR as previously described by Rossetti et al.
[25]. Briefly, lysates from samples were prepared as
DNA template [25,26]. Fifty μl of milk sediment was
added to 200 μl of lysis buffer (0.1 M Tris–HCl, pH 8.5,
0.05% Tween 20, 0.24 mg/ml proteinase K) and swabs
taken from gross lesions in organs and nasal swabs were
dipped for 1 min in 500 μl of lysis buffer. All lysates
were incubated for 1 h at 60°C and 15 min at 95°C as a
denaturation step. To identify M. bovis in samples, a
real-time PCR specific for M. bovis and targeting the
uvrC gene was further performed using a Ct cutoff value
of 40 [25,26]. This method detects approximately 2,000colony-forming units in the sediment of 1 ml of milk
and does not cross react with M. agalactiae, M. caprico-
lum subsp. capricolum, M. capricolum subsp. capripneu-
moniae, M. conjunctivae, M. hyopneumoniae, M. leachii,
M. putrefaciens, M. mycoides subsp. capri, M. mycoides
subsp. mycoides or 19 other bacterial species [25].
Statistical analysis
Raw data were checked for completeness and correct-
ness and corrected if needed. Observations with missing
values were removed from further analyses. Statistical
analyses were performed using SAS 9.3 (SAS Institute,
Cary, USA). In order to gather information on the long-
term history of included case and control herds, inci-
dence risks of pneumonia and arthritis were retrospect-
ively estimated for the 12-months-period prior to the
first herd visit. The incidence risk of M. bovis-associated
mastitis was estimated including cases confirmed by
PCR or bacterial culture up to 3 months prior to the
first visit only. The incidence rate of clinical M. bovis-as-
sociated mastitis between the two herd visits was esti-
mated for the lactating cow population at risk. Since all
herds had an all year round calving pattern, the number
of lactating cows was estimated by subtracting 14% from
the annual mean number of cows to exclude the dry
cow population according to Kretzschmar et al. [27]. Inci-
dence rates of clinical pneumonia were estimated separ-
ately for adult cows and young stock. In order to describe
the course of disease potentially related to M. bovis after
the first visit, incidence rates were estimated by dividing
the number of clinical cases by the animal years at risk,
which was estimated by multiplying the mean number of
animals by the length of the interval between the two
visits. Incidence rates were expressed as the number of
clinical M. bovis cases per animal year at risk.
To verify whether matching criteria of case and con-
trol herds concerning the herd size were met, the two
groups were compared by cross tabulations. In order to
assess whether case herds with a high prevalence of
M. bovis mastitis also had a high prevalence of pneumo-
nia in cows and calves, the Wilcoxon rank test was used.
Epidemiological data collected during the first visits in
case and control herds, respectively was analyzed using
univariable logisitic regression in order to identify poten-
tial herd-level risk factors associated with a M. bovis infec-
tion based on the Type 3 test for the case–control study
design. Correlation between potential herd-level risk fac-
tors was assessed using a Spearman rank correlation
matrix. Correlation was assumed to occur when the abso-
lute Spearman rank correlation coefficients were >0.50.
Significance level was set at P < 0.1 because of low statis-
tical power.
The study was conducted in accordance with the ani-
mal welfare legislation of Switzerland, all (including
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proved by the Federal Food Safety and Veterinary Office.
All farmers were thoroughly informed about the project
prior to the herd visit and gave their informed consent
for the sampling of milk specimens from their animals
and for completion of a questionnaire regarding herd
management practices.
Results
Analysis of samples
A total of 1,293 milk samples and 200 nasal swabs were
collected at the first herd visit in case and control herds
and analyzed by real-time-PCR. An overview of analyzed
samples in case herds is given in Table 2. A total of 18
(2.4%; 95%-CI: 1.5-3.8%) milk samples collected in case
herds during the first visit were M. bovis PCR positive
and were collected from cows suffering from clinical
mastitis with the typical symptoms of severe swelling
and changes of secretion followed by spreading of the
clinical signs to all four quarters. All milk samples col-
lected during the first herd visit from control herds were
PCR negative (Table 3). A total of 138 nasal swabs wereTable 2 Overview of collected samples in 19 case herds with
within a three-month-period prior to the first herd visit
Samples tested visit 1 Samples tested v
Milk Nasal swabs Milk
Case herd ID No PCR pos. No PCR pos. No PCR pos.
1 28 3 3 1 25 0
2 46 1 (4)* 8 0 37 0
3 8 1 3 1 9 0
4 46 1 10 0 42 0
5 44 1 10 8 45 0
6 32 0 4 1 36 0
7 19 1 2 1 19 0
8 63 1 0 0 62 0
9 34 0 16 4 40 0
10 60 4 9 4 57 0
11 33 0 12 2 38 0
12 50 3 13 7 40 0
13 87 0 6 3 0 0
14 49 2 3 3 38 0
15 19 0 16 6 20 0
16 15 0 7 1 17 0
17 52 0 5 1 49 0
18 20 0 7 1 16 0
19 37 0 (1)* 4 0 40 0
Total 742 18 138 44 630 0
*Number of samples analyzed shortly before the first herd visit in two different exte
for Clinical Microbiology and Infection Biology, Faculty of Veterinary Medicine, Viencollected during the first visit from case herds of which 44
(31.9%, 95%-CI: 24.7-40.1) were PCR positive for M. bovis.
Except for one transiently PCR-positive nasal swab of one
clinically healthy calf, there were no M. bovis positive ani-
mals found in control herds (Table 3). The calf was re-
examined and retested by a nasal swab within 50 days,
showing no clinical signs and a negative PCR result. The
collection of nasal swabs of 5% of cows present was not al-
ways reached, because adequate restraint of adult cows
was not possible in all housing systems and required more
assistance than available. Additionally, young stock (other
than calves younger than 3 months) was not present on all
farms visited during the summer months because of sea-
sonal alpine pasturing.
During the second visit to the case and control herds,
none of the cows showed the typical clinical signs of
M. bovis mastitis, and none of the milk samples tested
positive for M. bovis (Tables 2 and 3). In contrast, 28.0%
(26/93) PCR-positive nasal swabs were collected in 60%
(9/15) of case herds, at the second herd visit, which was
not significantly different from the prevalence at the first
herd visit (P = 0.52).at least one clinical case caused by Mycoplasma bovis
isit 2 Additional samples (positive)
Nasal swabs
No PCR pos. Milk (visit 1-visit 2) Lung Mammary gland
0 0 0 1 0
0 0 3 0 1
3 0 0 0 0
5 0 0 0 0
8 5 1 2 1
2 0 0 1 0
5 1 1 0 1
8 7 0 0 0
11 5 0 0 0
4 0 10 0 0
8 0 0 0 0
7 1 0 0 1
0 0 0 0 0
3 0 0 0 0
8 1 0 0 0
5 4 0 0 0
8 1 0 1 0
8 1 0 0 0
0 0 0 0 0
93 26 19 5 4
rnal diagnostic laboratories (Suisselab AG, Zollikofen, Switzerland, Department
na, Austria).
Table 3 Overview of collected samples in 17 control herds during the first and second herd visit
Samples tested visit 1 Samples tested visit 2
Milk Nasal swabs Milk Nasal swabs
Control herd ID No PCR pos. No PCR pos. No PCR pos. No PCR pos.
1 21 0 1 0 21 0 0 0
2 40 0 3 0 42 0 4 0
3 7 0 2 1 7 0 1 0
4* 36 0 0 0 0 0 0 0
5* 30 0 8 0 0 0 0 0
6* 18 0 6 0 0 0 0 0
7 18 0 2 0 19 0 2 0
8* 60 0 0 0 0 0 0 0
9* 32 0 6 0 0 0 0 0
10 58 0 4 0 54 0 4 0
11 46 0 9 0 38 0 0 0
12* 49 0 0 0 0 0 0 0
13 57 0 5 0 50 0 2 0
14 16 0 4 0 18 0 4 0
15 10 0 3 0 9 0 2 0
16* 25 0 4 0 0 0 0 0
17* 28 0 5 0 0 0 0 0
total 551 0 62 1 258 0 19 0
*Herds were not visited a second time.
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present in one case herd and no clinical pneumonia
cases were found in adult cows during the second visit.
Description of herds and herd-level risk factors
A total of 23 case herds and 17 control herds were vis-
ited during the study period. Four case herds were ex-
cluded from the case–control study because of
insufficient data, leaving 19 case and 17 control herds,
available for statistical analyses. No adequate control
herds could be found for two case herds. For the pur-
pose of the prospective cohort study, 18 case herds and
9 control herds were visited a second time. No control
herds had to be excluded because of a recent M. bovis
history. The mean herd size of case and control herds
was 41.1 (SD = 19.1) and 34.4 (SD = 16.1) lactating
cows, respectively (P = 0.26). Mean milk production in
case herds was 8,316 kg (SD = 1050.7) and 7,605.9 kg
(SD = 1089.9) in control herds and differed signifi-
cantly (P = 0.07). The following breeds were present in
the study herds: Brown Swiss (4 herds), Simmental (2
herds), Swiss-Fleckvieh-Red Holstein (19 herds), and
Holstein (7 herds). Three herds kept a mixture of
breeds.
An overview of the risk factors is given in Table 4. As-
sessment of milking routine revealed that case herds ap-
plied 4.7 and 7.5 times more often fore-stripping andadditional stimulation until milk let down, respectively,
than control herds. On case premises, cows were 15.0
times more often milked with a specific brand of milking
equipment and they also had a higher milk production
than cows in control herds. Stress-factors possibly af-
fecting the immune system including high in-barn
temperature, frequent animal movement (trade or >5
transportations per year), moldy feed, overcrowded
barn and concomitant disease were 5.6 and 4.4 times
more often identified in cows and calves of case herds
respectively compared to cows and calves of control
herds. Finally, case herds had 8.3 times more animal
movements due to trade and cattle shows than control
herds. The variables fore-stripping and additional stimula-
tion until milk ejection were correlated (Spearman rank
correlation coefficient was 0.51); other risk factor pairs
were not.
Implementation of the following recommendations to
decrease M. bovis-associated disease was recorded dur-
ing the second visit to case farms. Eighteen of nineteen
case farmers culled the clinically diseased animals within
approximately one week from the herd visit and two
case farmers changed their milking routine. One farmer
switched to a new cleaning material and the other used
a different dipping solution. None of the case farmers
isolated the diseased animals and no changes were made
in calf-housing.
Table 4 Risk factors associated with the herd-level presence of Mycoplasma bovis in univariable logistic regression
models
Variable Category Frequency Frequency and
prevalence (%)
of case herds
OR 90% confidence interval P- value
lower upper
Brand of milking equipment* Special brand
Other brands
14 21 12 (85.7) 6 (28.6) 15.0 3.4 66.3 0.003
Milk Production of herd
(increase of 100 kg)
Continuous Mean = 79.7, SD = 11.1 1.067 1.006 1.13 0.07
Presence of stress factors cows** Yes No 16 20 12 (75.0) 7 (35.0) 5.6 1.6 18.9 0.02
Presence of stress-factors calves*** Yes No 9 27 7 (77.8) 12 (44.4) 4.4 1.01 18.9 0.1
Animal movement
(trade and exposition)
Yes No 12 24 10 (83.3) 9 (37.5) 8.3 2.0 35.5 0.02
Fore-stripping Yes No 25 11 16 (64.0) 3 (27.3) 4.7 1.3 17.5 0.05
Additional stimulation until
milk ejection
Yes No 30 6 18 (60.0) 1 (16.7) 7.5 1.1 50.3 0.08
Significance was set at P < 0.1.
*Information on brand of milking system is missing for one farm.
**Stress-factors cows include: overcrowding, moldy feed, high in-barn temperature, frequent transportation, concomitant disease.
***Stress-factors calves include: overcrowding, concomitant disease, high degree of calf traffic.
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In 12 case herds (63%), clinical mastitis was the predom-
inant clinical symptom, whereas in the remaining seven
case herds (37%), the predominant clinical finding was
pneumonia in cows. In case herds, the incidence risk of
M. bovis mastitis within 3 months prior to the first visit
ranged from 0.01 to 0.13 (Figure 1). Arthritis was ob-
served in three case herds, otitis media/interna in calves
in one case herd. Within-herd incidence risk of pneumo-
nia in cows, pneumonia in calves, arthritis in cows and
arthritis during the 12-month-period prior to the first
visit are shown in Figure 2 and ranged from 0 to 0.60 in
case herds. The incidence risk of clinical pneumonia in
calves and cows in control herds is displayed in Figure 3.
Case herds reported significantly more cases of clinical
pneumonia during the 12-month-period prior to the first
herd visit in cows (P = 0.006) and calves (P = 0.1), respect-
ively, than control herds. Additionally, no differences inFigure 1 Incidence risk of Mycoplasma Bovis-associated mastitis in cathe herd rankings for incidence risk of M. bovis-associated
mastitis and the herd rankings for incidence risk of clinical
pneumonia in calves (P = 0.64) or in cows (P = 0.97) could
be identified.
Incidence rate estimation of clinical mastitis and clin-
ical pneumonia in the prospective cohort study (i.e., be-
tween the two visits) revealed that only in three case
herds new clinical cases occurred: Case herd number 1
had a pneumonia incidence rate in cows of 0.6 per ani-
mal year at risk but no new mastitis cases were identi-
fied. Case herd number 11 had an incidence rate of
clinical pneumonia in cows of 0.3 per animal year at risk.
Case herd number 5 had a clinical pneumonia incidence
rate in cows of 0.1 per animal year at risk and a clinical
mastitis incidence rate of 0.1 per animal year at risk. In
case herds 1 and 11, incidence rates of clinical pneumo-
nia in calves were 0.2 and 0.1 per animal year at risk,
respectively.se herds in the three month-period prior to the first herd visit.
Figure 2 Incidence risk of pneumonia and arthritis in calves and cows (according to the definitions given in the material and methods
section) in case herds in the 12-month-period prior to the first herd visit.
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and incidence rate of mastitis due to M. bovis in the nine
control herds visited a second time was 0 per animal year
at risk. Information on disease of young stock that was
seasonally pastured on alpine farms was not available.
Discussion
Retrospective case–control study: herd-level risk factors
The rather low prevalence of animals with clinical signs
of M. bovis-associated disease supports the hypothesis
that M. bovis is an opportunistic pathogen that needs
certain circumstances to induce clinical disease as previ-
ously suggested [17]. The herd-level risk factors identi-
fied in this study may contribute to these circumstances.
A high rate of animal movements because of trade or
showing was associated with clinical disease due to M.
bovis for instance. Contact of susceptible animals withFigure 3 Incidence risk of pneumonia in calves and cows (according t
control herds 12-months prior to the first visit. Data on the exact num
risk of pneumonia in calves could not be estimated for this herd.infected animals outside the herd of origin and stress
due to transportation and cattle shows may explain this.
Interestingly, replacement purchase was not associated
with being a case herd in our study and suggested else-
where [2,16,17,22]. This might be due to the low rate of
purchased animals in the respective herds and the low
statistical power of the study. On the other hand, typing
of M. bovis strains from all case herds was done in an-
other study [26] and showed the presence of herd-
specific strains. This implies that contact to other
infected animals as the source of infection is unlikely.
Moreover, it has been suggested that the stress of trans-
port itself rather than contact to other animals (exposure
to “new” strains) constitutes the risk factor [28]. Also, a
high rate of animal movements particularly the visit to
cattle shows might be related to the production level of
the herds.o the definition given in the material and methods section) in
ber of calves of control herd 10 was not available; therefore incidence
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such as moldy feed, overcrowding in the barn and con-
comitant disease were present significantly more often in
case herds than in control herds. Fink-Gremmels in 2007
[29] reviewed the impact of various mycotoxins on health
and performance of dairy cows and concluded that inter-
action of mycotoxins can impede their rumen degradation
and be a threat to metabolic, hormonal and immuno-
logical function of exposed individuals. It was also shown
that the fusarium toxin deoxynivalenol present in naturally
contaminated feed impaired nonspecific immunity by de-
creasing phagocytic function of neutrophils [30]. Add-
itionally, case herds had a higher average milk production
than control herds as previously described by Feenstra
et al. [31]. This may indicate that cows from case herds
were at a higher risk to be in a negative energy balance if
not fed adequately and, therefore, might have been more
susceptible to infectious diseases [32,33].
Case herds practiced significantly more often fore-
stripping and additional stimulation until proper milk let
down, indicating a more appropriate milking routine than
applied in control herds. There seems to be no obvious
biological reason why fore-stripping should increase the
risk of M. bovis associated mastitis and has to be inter-
preted with care due to the limited statistical power in the
present study. However, manual stimulation of the udder
and the teats before attachment of the milking clusters is
accompanied by a more intensive contact of the poten-
tially contaminated milkers’ hands with the teat ends and
may increase the risk of infection of the mammary gland.
Reverse causality of the factor “fore-stripping” could be
excluded in all case herds since changes in milking routine
after the start of the outbreak were only introduced in two
herds. It included the usage of a different cleaning material
in one herd and the introduction of post milking teat dis-
infection in the other herd. It is therefore not assumed
that farmers of case herds applied fore-stripping to control
the M. bovis outbreak.
The strongest risk factor identified in the univariable
logistic regression models was “brand of milking equip-
ment”. This factor has to be interpreted as a confounder
for being a M. bovis herd, because the estimates of other
explanatory variables changed >20% when this variable
was added to multivariable logistic regression models
[34] (data not shown).
Descriptive results and prospective cohort study
In 17 out of 19 case herds, a high incidence risk of clin-
ical pneumonia in cows and calves was present within
the one-year-period prior to the outbreak when com-
pared to control herds. Case herds with a high incidence
risk of clinical pneumonia in cows or calves in the 12-
month-period prior to the first visit also suffered from
the highest incidence risk of M. bovis-associated mastitiswithin the three-month-period prior to the first visit. Al-
though the involvement of M. bovis in the pneumonia
cases recorded during the 12-month-period prior to the
first visit was not confirmed by bacteriological examin-
ation, it can be hypothesized that M. bovis was already
present in the case herds for some time without causing
additional disease such as mastitis and arthritis [16]. Per-
sonal experience from former herd investigations (MB)
have shown that the incidence of clinical pneumonia in
adult cattle is often increased prior to an outbreak of
M. bovis-associated mastitis. The time period of three
months for inclusion of M. bovis associated clinical mas-
titis cases was also based on experience from former in-
vestigations of infected herds (MB). Within case herds, the
prevalence of M. bovis-associated mastitis varied between
0.01 and 0.13, which agrees with previous results [23].
Arthritis in adult cattle was only observed in three
herds and with very low incidence risks (0.06, 0.06 and
0.02 respectively). M. bovis-associated arthritis in adult
cattle is often described as sporadic [3]. In contrast to
dairy herds, prevalence of the chronic pneumonia and
polyarthritis syndrome of up to 28% were reported in
Canadian feedlot cattle [5], which might be attributable
to commingling of animals from different herds of origin
increasing the risk of social stress and introduction of
pathogens.
The possible spread of M. bovis by feeding contami-
nated milk to calves has been reported previously
[23,24,35], and recently, Maunsell et al. [36] demon-
strated that colonization of tonsils occurred after oral in-
oculation of calves with M. bovis. This might play an
important role under Swiss conditions, where young
calves and cows are often housed in the same barn, and
replacement calves are fed almost exclusively with
unpasteurized milk. M. bovis is also capable of forming
biofilms on smooth surfaces (glass) and microtitre plates
[37] and it might therefore also be able to survive on
drinking nipples, which could be an important fomite
for the spread of mycoplasmas when feeding several
calves with the same drinking equipment. This, however,
could not be statistically confirmed in the present study.
When interpreting incidence rates of disease attribut-
able to M. bovis between the first and second visit, there
were only three case herds reporting additional cases of
mastitis (case herds 5 and 7) and pneumonia (case herds
1 and 5). Case herd 5 had a major problem with over-
crowding in the barn, and cows and calves were housed
close to each other. Additionally, the owner of case herd
5 neither isolated nor culled one of the cows with a con-
firmed clinical mastitis and pneumonia due to M. bovis,
which might have contributed to the prolonged course of
clinical disease in this herd. The prevalence of clinical mas-
titis, pneumonia and polyarthritis in cows due to M. bovis
at the second visit decreased to 0% in all the case herds
Aebi et al. Acta Veterinaria Scandinavica  (2015) 57:10 Page 10 of 11visited twice (n = 18). This indicates that clinical disease
was either self-limiting or that implementation of manage-
ment improvement was lowering the within-herd trans-
mission of M. bovis, especially in the case of
intramammary infection, as reported previously
[2,21-23,38]. Randomized field trials are needed to deter-
mine the true effectiveness of these interventions.Limitations
Since the most important limitation of the present study
was the small sample size, an additional multivariable logis-
tic regression analysis correcting for confounding and co-
linearity could not be completed because of insufficient
statistical power. Therefore, the results of the univariable
regression analysis have to be interpreted with caution. We
are also aware that in control herds potentially infected an-
imals might have been missed since an insufficient number
of nasal swabs was collected. However, none of the nasal
swabs and none of the milk samples of the nine revisited
control herds were positive for M. bovis. Despite these lim-
itations, except for the risk factor “fore-stripping” and the
confounding factor “use of a specific brand of milking
equipment”, the significant risk factors can be explained
biologically.Conclusions
Using a combination of study designs, this investigation
identified some interesting aspects of M. bovis infection
in Swiss dairy cattle herds. In the retrospective case–
control study, risk factors such as high milk production,
presence of frequent animal movements, moldy feed and
overcrowding were associated with an outbreak of clin-
ical M. bovis disease. The prospective part of the investi-
gation showed an improvement in the herds’ M. bovis
status but a prolonged colonization in clinically healthy
animals was also identified. Young stock, as a reservoir
for M. bovis, should be taken into account in future con-
trol strategies.
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